Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Azacitidine,"AML, blast count above 30% -widened access",Azacitidine,,,Oncology Agents and Immunosuppressants
